LONDON, Jan. 23, 2018 /PRNewswire/ -- The boost in demand of sterilization processes is due to the increasing prevalence of healthcare associated infections (HAIs), growing demand for sterilized pharmaceutical products, expanding demand for less invasive surgical procedures, and growing aging population.

Insights on market segments
In terms of products & services, the sterilization technology market has been segmented into devices, consumables and services. The devices market occupied the largest share in the global market in 2016, mainly attributable to the increasing number of HAIs, growing number of hospitals, rising pharmaceutical, biotechnologies and medical device industries.


The vendors in this market offer two major types of sterilization services, contract sterilization and sterilization validation, of which contract sterilization services occupy the larger share in the market.

There are various sterilization technology devices available in the market that are based on steam, low temperature, heat, radiation, filtration, liquid, and ultrasound. Among different type of devices, heat sterilizers are expected to register the fastest growth of 9.3%, in the sterilization technology market during the forecast period. Its growth is due to the increasing adoption of heat sterilizers in the instrument reprocessing operations, pharmaceutical and biotechnology manufacturing units for sterilization of bulk product for sterilizing products that are moisture sensitive and are medicinal in nature and cannot be sterilized with steam.

On the basis of application, the sterilization technology industry is segmented into medical devices and pharmaceutical sterilization. Medical devices sterilization projected the larger share of 59.0% in 2016 in the global revenue, attributed to growing aging population and increasing number of surgeries, that have increased the need of advanced invasive devices, boosting the demand of sterilization technology operations for complex medical devices.

Pharmaceutical and biotechnology companies are the largest end user in the sterilization technology market and are expected to generate a revenue of $3.2 million by 2023. The growing number of pharmaceutical and biotechnology companies and increasing production of pharmaceutical and biotechnology products is boosting the growth of this segment. Other than these companies, hospitals, medical device companies, ambulatory surgical centers and clinics, and academic and research organizations are the other key end users in the market.

Infection Control Homepage